Fibrinogen Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
The global Fibrinogen Testing market is poised for exponential growth between 2024 and 2031, driven by a host of key factors that underscore its significance in healthcare. Fibrinogen, a crucial glycoprotein in the body essential for blood circulation, is undergoing a surge in testing due to its pivotal role in managing various health conditions, including diabetes and blood clotting disorders. This market is projected to reach USD 300 Million by 2031, up from USD 195 Million in 2024.
Key Drivers to the Fibrinogen Testing Market
1. Increase in the Prevalence of Chronic Diseases: The escalating prevalence of chronic diseases such as diabetes, closely linked to blood clotting issues, is driving the demand for fibrinogen testing. As the global population grapples with lifestyle disorders, monitoring fibrinogen levels in the blood becomes critical for timely intervention.
2. Increased Prevalence of Blood Clotting Disorders: A growing number of individuals are affected by blood clotting disorders, necessitating regular fibrinogen testing. Additionally, increased healthcare spending and new market entrants are stimulating market growth.
3. Increased Adoption of Coagulation Instruments and Reagents: The adoption of advanced coagulation instruments and reagents, catering to the need for rapid and efficient testing, is on the rise. Privatization of diagnostic laboratories to offer enhanced services is further bolstering market growth.
4. An Increase in Anticoagulant Therapy Procedures: Anticoagulant therapies, both traditional and novel, are extensively used for various clotting disorders. Consistent blood tests, including fibrinogen testing, are essential to gauge the effectiveness of these therapies, driving market expansion.
Restraints on the Fibrinogen Testing Market
High Cost of Equipment & Low Awareness: The cost associated with fibrinogen testing equipment limits its accessibility primarily to major healthcare institutes and labs. This cost barrier may hinder market growth. Additionally, a lack of awareness in developing countries presents a challenge to unlocking the market's full potential.
Impact of COVID-19 on Fibrinogen Testing Market
The COVID-19 pandemic brought about significant disruptions in the Fibrinogen Testing market. Lockdowns and supply chain interruptions led to a temporary decline in testing. However, as the situation improved and restrictions eased, the demand for Fibrinogen Testing rebounded, underscoring its resilience in the face of adversity.
Competitive Landscape
The Fibrinogen Testing Market is highly competitive, featuring numerous prominent players. Major industry leaders are focused on diversifying their product offerings to enhance revenue and market share.
Key Companies Profiled
• Thermo Fisher Scientific Inc.
• Grifols
• Helena Laboratories Corporation
• Stago
• TULIP DIAGNOSTICS (P) LTD
• Werfen
• Biosystems S.A.
• Randox Laboratories Ltd.
• Technoclone
• Medirox AB
• MedTest
• Enzyme Research Laboratories (r2 Diagnostics)
• Kamiya biomedical Company
• Pathway Diagnostics Limited
Fibrinogen Testing Market Segmentation
Fibrinogen Testing Market by Reagent Type
• Q.F.A. Thrombin Kits
• Fibrinogen Kits
• Multifibren U Kits
• STA-fibrinogen Kits
• Imidazole Buffer Kits
Fibrinogen Testing Market by Indication
• Congenital Fibrinogen Disorders
• Fibrinogen storage disease
• Hereditary fibrinogen Aα-Chain amyloidosis,
• Acquired dysfibrinogenemia
• Cryofibrinogenemia
• Disseminated Intravascular Coagulation (DIC)
• End-Stage Liver Disease
Fibrinogen Testing Market by End User
• Hospitals
• Clinics
• Diagnostic Laboratories
• Ambulatory Care Centers
• Academics & Research Institutes
Fibrinogen Testing Market by Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa (MEA)
Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.
- 1. Executive Summary
- 1.1. Global Fibrinogen Testing Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value and Volume, 2023
- 1.5. Analyst Recommendations
- 2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. Porter’s Five Forces Analysis
- 2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
- 2.6. Impact of Ukraine-Russia Conflict
- 2.7. Economic Overview
- 2.7.1. World Economic Projections
- 2.8. PESTLE Analysis
- 3. Price Analysis, 2018 – 2023
- 3.1. Global Average Price Analysis, by Reagent/ Application, US$ Per Unit, 2018 – 2023
- 3.2. Prominent Factor Affecting Breast Tissue Markers Prices
- 3.3. Global Average Price Analysis, by Region, US$ Per Unit
- 4. Global Fibrinogen Testing Market Outlook, 2018 – 2031
- 4.1. Global Fibrinogen Testing Market Outlook, by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 4.1.1. Key Highlights
- 4.1.1.1. Q.F.A. Thrombin Kits
- 4.1.1.2. Fibrinogen Kits
- 4.1.1.3. Multifibren U Kits
- 4.1.1.4. STA-fibrinogen Kits
- 4.1.1.5. Imidazole Buffer Kits
- 4.2. Global Fibrinogen Testing Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 4.2.1. Key Highlights
- 4.2.1.1. Congenital Fibrinogen Disorders
- 4.2.1.2. Fibrinogen storage disease
- 4.2.1.3. Hereditary fibrinogen Aα-Chain amyloidosis,
- 4.2.1.4. Acquired dysfibrinogenemia
- 4.2.1.5. Cryofibrinogenemia
- 4.2.1.6. Disseminated Intravascular Coagulation (DIC)
- 4.2.1.7. End-Stage Liver Disease
- 4.3. Global Fibrinogen Testing Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 4.3.1. Key Highlights
- 4.3.1.1. Hospitals
- 4.3.1.2. Clinics
- 4.3.1.3. Diagnostic Laboratories
- 4.3.1.4. Ambulatory Care Centres
- 4.3.1.5. Academics & Research Institutes
- 4.4. Global Fibrinogen Testing Market Outlook, by Region, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 4.4.1. Key Highlights
- 4.4.1.1. North America
- 4.4.1.2. Europe
- 4.4.1.3. Asia Pacific
- 4.4.1.4. Latin America
- 4.4.1.5. Middle East & Africa
- 5. North America Fibrinogen Testing Market Outlook, 2018 – 2031
- 5.1. North America Fibrinogen Testing Market Outlook, by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 5.1.1. Key Highlights
- 5.1.1.1. Q.F.A. Thrombin Kits
- 5.1.1.2. Fibrinogen Kits
- 5.1.1.3. Multifibren U Kits
- 5.1.1.4. STA-fibrinogen Kits
- 5.1.1.5. Imidazole Buffer Kits
- 5.2. North America Fibrinogen Testing Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 5.2.1. Key Highlights
- 5.2.1.1. Congenital Fibrinogen Disorders
- 5.2.1.2. Fibrinogen storage disease
- 5.2.1.3. Hereditary fibrinogen Aα-Chain amyloidosis,
- 5.2.1.4. Acquired dysfibrinogenemia
- 5.2.1.5. Cryofibrinogenemia
- 5.2.1.6. Disseminated Intravascular Coagulation (DIC)
- 5.2.1.7. End-Stage Liver Disease
- 5.3. North America Fibrinogen Testing Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 5.3.1. Key Highlights
- 5.3.1.1. Hospitals
- 5.3.1.2. Clinics
- 5.3.1.3. Diagnostic Laboratories
- 5.3.1.4. Ambulatory Care Centres
- 5.3.1.5. Academics & Research Institutes
- 5.4. North America Fibrinogen Testing Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 5.4.1. Key Highlights
- 5.4.1.1. U.S. Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 5.4.1.2. U.S. Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 5.4.1.3. U.S. Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 5.4.1.4. Canada Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 5.4.1.5. Canada Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 5.4.1.6. Canada Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 5.4.2. BPS Analysis/Market Attractiveness Analysis
- 6. Europe Fibrinogen Testing Market Outlook, 2018 – 2031
- 6.1. Europe Fibrinogen Testing Market Outlook, by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.1.1. Key Highlights
- 6.1.1.1. Q.F.A. Thrombin Kits
- 6.1.1.2. Fibrinogen Kits
- 6.1.1.3. Multifibren U Kits
- 6.1.1.4. STA-fibrinogen Kits
- 6.1.1.5. Imidazole Buffer Kits
- 6.2. Europe Fibrinogen Testing Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.2.1. Key Highlights
- 6.2.1.1. Congenital Fibrinogen Disorders
- 6.2.1.2. Fibrinogen storage disease
- 6.2.1.3. Hereditary fibrinogen Aα-Chain amyloidosis,
- 6.2.1.4. Acquired dysfibrinogenemia
- 6.2.1.5. Cryofibrinogenemia
- 6.2.1.6. Disseminated Intravascular Coagulation (DIC)
- 6.2.1.7. End-Stage Liver Disease
- 6.3. Europe Fibrinogen Testing Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.3.1. Key Highlights
- 6.3.1.1. Hospitals
- 6.3.1.2. Clinics
- 6.3.1.3. Diagnostic Laboratories
- 6.3.1.4. Ambulatory Care Centres
- 6.3.1.5. Academics & Research Institutes
- 6.4. Europe Fibrinogen Testing Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.4.1. Key Highlights
- 6.4.1.1. Germany Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.4.1.2. Germany Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.4.1.3. Germany Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.4.1.4. U.K. Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.4.1.5. U.K. Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.4.1.6. U.K. Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.4.1.7. France Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.4.1.8. France Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.4.1.9. France Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.4.1.10. Italy Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.4.1.11. Italy Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.4.1.12. Italy Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.4.1.13. Turkey Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.4.1.14. Turkey Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.4.1.15. Turkey Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.4.1.16. Russia Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.4.1.17. Russia Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.4.1.18. Russia Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.4.1.19. Rest of Europe Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.4.1.20. Rest of Europe Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.4.1.21. Rest of Europe Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 6.4.2. BPS Analysis/Market Attractiveness Analysis
- 7. Asia Pacific Fibrinogen Testing Market Outlook, 2018 – 2031
- 7.1. Asia Pacific Fibrinogen Testing Market Outlook, by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 7.1.1. Key Highlights
- 7.1.1.1. Q.F.A. Thrombin Kits
- 7.1.1.2. Fibrinogen Kits
- 7.1.1.3. Multifibren U Kits
- 7.1.1.4. STA-fibrinogen Kits
- 7.1.1.5. Imidazole Buffer Kits
- 7.2. Asia Pacific Fibrinogen Testing Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 7.2.1. Key Highlights
- 7.2.1.1. Congenital Fibrinogen Disorders
- 7.2.1.2. Fibrinogen storage disease
- 7.2.1.3. Hereditary fibrinogen Aα-Chain amyloidosis,
- 7.2.1.4. Acquired dysfibrinogenemia
- 7.2.1.5. Cryofibrinogenemia
- 7.2.1.6. Disseminated Intravascular Coagulation (DIC)
- 7.2.1.7. End-Stage Liver Disease
- 7.3. Asia Pacific Fibrinogen Testing Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 7.3.1. Key Highlights
- 7.3.1.1. Hospitals
- 7.3.1.2. Clinics
- 7.3.1.3. Diagnostic Laboratories
- 7.3.1.4. Ambulatory Care Centres
- 7.3.1.5. Academics & Research Institutes
- 7.4. Asia Pacific Fibrinogen Testing Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 7.4.1. Key Highlights
- 7.4.1.1. China Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 7.4.1.2. China Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 7.4.1.3. China Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 7.4.1.4. Japan Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 7.4.1.5. Japan Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 7.4.1.6. Japan Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 7.4.1.7. South Korea Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 7.4.1.8. South Korea Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 7.4.1.9. South Korea Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 7.4.1.10. India Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 7.4.1.11. India Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 7.4.1.12. India Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 7.4.1.13. Southeast Asia Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 7.4.1.14. Southeast Asia Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 7.4.1.15. Southeast Asia Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 7.4.1.16. Rest of Asia Pacific Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 7.4.1.17. Rest of Asia Pacific Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 7.4.1.18. Rest of Asia Pacific Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 7.4.2. BPS Analysis/Market Attractiveness Analysis
- 8. Latin America Fibrinogen Testing Market Outlook, 2018 – 2031
- 8.1. Latin America Fibrinogen Testing Market Outlook, by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 8.1.1. Key Highlights
- 8.1.1.1. Q.F.A. Thrombin Kits
- 8.1.1.2. Fibrinogen Kits
- 8.1.1.3. Multifibren U Kits
- 8.1.1.4. STA-fibrinogen Kits
- 8.1.1.5. Imidazole Buffer Kits
- 8.2. Latin America Fibrinogen Testing Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 8.2.1.1. Congenital Fibrinogen Disorders
- 8.2.1.2. Fibrinogen storage disease
- 8.2.1.3. Hereditary fibrinogen Aα-Chain amyloidosis,
- 8.2.1.4. Acquired dysfibrinogenemia
- 8.2.1.5. Cryofibrinogenemia
- 8.2.1.6. Disseminated Intravascular Coagulation (DIC)
- 8.2.1.7. End-Stage Liver Disease
- 8.3. Latin America Fibrinogen Testing Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 8.3.1. Key Highlights
- 8.3.1.1. Hospitals
- 8.3.1.2. Clinics
- 8.3.1.3. Diagnostic Laboratories
- 8.3.1.4. Ambulatory Care Centres
- 8.3.1.5. Academics & Research Institutes
- 8.4. Latin America Fibrinogen Testing Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 8.4.1. Key Highlights
- 8.4.1.1. Brazil Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 8.4.1.2. Brazil Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 8.4.1.3. Brazil Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 8.4.1.4. Mexico Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 8.4.1.5. Mexico Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 8.4.1.6. Mexico Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 8.4.1.7. Argentina Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 8.4.1.8. Argentina Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 8.4.1.9. Argentina Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 8.4.1.10. Rest of Latin America Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 8.4.1.11. Rest of Latin America Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 8.4.1.12. Rest of Latin America Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 8.4.2. BPS Analysis/Market Attractiveness Analysis
- 9. Middle East & Africa Fibrinogen Testing Market Outlook, 2018 – 2031
- 9.1. Middle East & Africa Fibrinogen Testing Market Outlook, by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 9.1.1. Key Highlights
- 9.1.1.1. Q.F.A. Thrombin Kits
- 9.1.1.2. Fibrinogen Kits
- 9.1.1.3. Multifibren U Kits
- 9.1.1.4. STA-fibrinogen Kits
- 9.1.1.5. Imidazole Buffer Kits
- 9.2. Middle East & Africa Fibrinogen Testing Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 9.2.1. Key Highlights
- 9.2.1.1. Scientific Research
- 9.2.1.2. Medical Diagnostics
- 9.2.1.3. Agricultural Application
- 9.2.1.4. Food & Beverages
- 9.2.1.5. Other Applications
- 9.3. Middle East & Africa Fibrinogen Testing Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 9.3.1. Key Highlights
- 9.3.1.1. Hospitals
- 9.3.1.2. Clinics
- 9.3.1.3. Diagnostic Laboratories
- 9.3.1.4. Ambulatory Care Centres
- 9.3.1.5. Academics & Research Institutes
- 9.4. Middle East & Africa Fibrinogen Testing Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 9.4.1. Key Highlights
- 9.4.1.1. GCC Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 9.4.1.2. GCC Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 9.4.1.3. GCC Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 9.4.1.4. South Africa Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 9.4.1.5. South Africa Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 9.4.1.6. South Africa Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 9.4.1.7. Egypt Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 9.4.1.8. Egypt Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 9.4.1.9. Egypt Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 9.4.1.10. Nigeria Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 9.4.1.11. Nigeria Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 9.4.1.12. Nigeria Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 9.4.1.13. Rest of Middle East & Africa Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 9.4.1.14. Rest of Middle East & Africa Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 9.4.1.15. Rest of Middle East & Africa Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 – 2031
- 9.4.2. BPS Analysis/Market Attractiveness Analysis
- 10. Competitive Landscape
- 10.1. Artery Type vs Indication Heatmap
- 10.2. Manufacturer vs Indication Heatmap
- 10.3. Company Market Share Analysis, 2023
- 10.4. Competitive Dashboard
- 10.5. Company Profiles
- 10.5.1. Thermo Fisher Scientific Inc.
- 10.5.1.1. Company Overview
- 10.5.1.2. Product Portfolio
- 10.5.1.3. Financial Overview
- 10.5.1.4. Business Strategies and Development
- 10.5.2. Grifols
- 10.5.2.1. Company Overview
- 10.5.2.2. Product Portfolio
- 10.5.2.3. Financial Overview
- 10.5.2.4. Business Strategies and Development
- 10.5.3. Helena Laboratories Corporation
- 10.5.3.1. Company Overview
- 10.5.3.2. Product Portfolio
- 10.5.3.3. Financial Overview
- 10.5.3.4. Business Strategies and Development
- 10.5.4. Stago
- 10.5.4.1. Company Overview
- 10.5.4.2. Product Portfolio
- 10.5.4.3. Financial Overview
- 10.5.4.4. Business Strategies and Development
- 10.5.5. TULIP DIAGNOSTICS (P) LTD
- 10.5.5.1. Company Overview
- 10.5.5.2. Product Portfolio
- 10.5.5.3. Financial Overview
- 10.5.5.4. Business Strategies and Development
- 10.5.6. Werfen
- 10.5.6.1. Company Overview
- 10.5.6.2. Product Portfolio
- 10.5.6.3. Financial Overview
- 10.5.6.4. Business Strategies and Development
- 10.5.7. Biosystems S.A.
- 10.5.7.1. Company Overview
- 10.5.7.2. Product Portfolio
- 10.5.7.3. Financial Overview
- 10.5.7.4. Business Strategies and Development
- 10.5.8. Randox Laboratories Ltd.
- 10.5.8.1. Company Overview
- 10.5.8.2. Product Portfolio
- 10.5.8.3. Financial Overview
- 10.5.8.4. Business Strategies and Development
- 10.5.9. Technoclone
- 10.5.9.1. Company Overview
- 10.5.9.2. Product Portfolio
- 10.5.9.3. Financial Overview
- 10.5.9.4. Business Strategies and Development
- 10.5.10. Medirox AB
- 10.5.10.1. Company Overview
- 10.5.10.2. Product Portfolio
- 10.5.10.3. Financial Overview
- 10.5.10.4. Business Strategies and Development
- 10.5.11. MedTest
- 10.5.11.1. Company Overview
- 10.5.11.2. Product Portfolio
- 10.5.11.3. Financial Overview
- 10.5.11.4. Business Strategies and Development
- 11. Appendix
- 11.1. Research Methodology
- 11.2. Report Assumptions
- 11.3. Acronyms and Abbreviations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook